Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies

NACompletedINTERVENTIONAL
Enrollment

21,752

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Diabetes MellitusCardiovascular Disease
Interventions
OTHER

Interactive Voice Recognition (IVR) phone calls

"The IVR intervention consisted of automated phone calls designed to educate participants about their medications and to assist them in refilling their prescriptions. The calls fell into two basic types: simple refill reminders and tardy calls for those who were overdue for a refill. Calls occured monthly and were triggered by dispensing information in the electronic medical record (EMR). Call features included the ability to transfer individuals to Kaiser's automated prescription refill service as well as to care managers. Although the calls were triggered by and focused on use of ACE inhibitors, ARBs and statins, they also included reminders to use aspirin, which is known to also be effective for secondary prevention in this patient population."

OTHER

Educational mailings and follow-up for nonadherence

Participants received bimonthly educational materials by mail. In addition, patients received mailed refill reminder letters and their providers were notified electronically if the patients failed to refill in response to the automated calls. The educational mailings included personalized health information such as the participant's cholesterol and blood pressure readings, as well as tools for improving adherence such as frequently asked questions (FAQs) about their medications, a pocket-sized calendar for tracking refills with pertinent phone numbers and web site information and space for them to write their medical record number and prescription numbers.

Trial Locations (3)

30305

Center for Health Research, Kaiser Permanente Southeast, Atlanta

96817

Center for Health Research, Kaiser Permanente Hawaii, Honolulu

97227

Center for Health Research, Kaiser Permanente Northwest, Portland

All Listed Sponsors
collaborator

Kaiser Foundation Hospitals, Center for Health Research

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Kaiser Permanente

OTHER

NCT01251757 - Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies | Biotech Hunter | Biotech Hunter